Zealand Pharma A/S (CO:ZEAL) — Stock Price
Zealand Pharma A/S (CO:ZEAL) is currently trading at Dkr326.00 DKK, down 1.51% today. Over the past 52 weeks, shares have ranged between Dkr234.90 and Dkr545.80. This page tracks Zealand Pharma A/S's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Zealand Pharma A/S stock valuation.
Zealand Pharma A/S (ZEAL) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Zealand Pharma A/S's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Zealand Pharma A/S Income Statement — Revenue, Profit & Earnings by Year
Zealand Pharma A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Dkr9.21 Billion | Dkr62.69 Million | Dkr342.79 Million | Dkr103.99 Million | Dkr292.57 Million |
| Cost of Revenue | Dkr28.19 Million | Dkr7.87 Million | Dkr19.17 Million | Dkr30.71 Million | Dkr118.81 Million |
| Gross Profit | Dkr9.19 Billion | Dkr54.82 Million | Dkr323.61 Million | Dkr73.28 Million | Dkr173.75 Million |
| Research & Development | Dkr1.58 Billion | Dkr919.87 Million | Dkr684.90 Million | Dkr614.04 Million | Dkr588.45 Million |
| SG&A | — | Dkr160.51 Million | Dkr73.80 Million | Dkr274.24 Million | Dkr260.99 Million |
| Total Operating Expenses | Dkr2.03 Billion | Dkr1.33 Billion | Dkr895.85 Million | Dkr920.59 Million | Dkr1.22 Billion |
| Operating Income | Dkr7.16 Billion | Dkr-1.27 Billion | Dkr-572.24 Million | Dkr-816.60 Million | Dkr-1.05 Billion |
| EBITDA | Dkr7.18 Billion | Dkr-1.02 Billion | Dkr-651.58 Million | Dkr-884.88 Million | Dkr-729.68 Million |
| EBIT | Dkr7.16 Billion | Dkr-1.04 Billion | Dkr-676.67 Million | Dkr-915.59 Million | Dkr-754.80 Million |
| Interest Expense | Dkr37.70 Million | Dkr40.90 Million | Dkr28.98 Million | Dkr56.45 Million | Dkr4.09 Million |
| Income Before Tax | Dkr7.00 Billion | Dkr-1.08 Billion | Dkr-708.87 Million | Dkr-972.04 Million | Dkr-1.03 Billion |
| Income Tax Expense | Dkr546.06 Million | Dkr-4.62 Million | Dkr-5.13 Million | Dkr-6.43 Million | Dkr-8.79 Million |
| Net Income | Dkr6.46 Billion | Dkr-1.08 Billion | Dkr-703.74 Million | Dkr-965.61 Million | Dkr-1.02 Billion |
Zealand Pharma A/S Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Zealand Pharma A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Dkr16.46 Billion | Dkr9.51 Billion | Dkr1.98 Billion | Dkr1.54 Billion | Dkr2.07 Billion |
| Total Current Assets | Dkr15.67 Billion | Dkr8.53 Billion | Dkr1.78 Billion | Dkr1.32 Billion | Dkr1.72 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | Dkr10.53 Billion | Dkr7.75 Billion | Dkr1.18 Billion | Dkr108.61 Million | Dkr299.04 Million |
| Net Receivables | Dkr319.69 Million | Dkr138.97 Million | Dkr122.36 Million | Dkr137.22 Million | Dkr153.45 Million |
| Inventory | — | Dkr10.70 Million | Dkr7.93 Million | Dkr1.29 Million | Dkr118.44 Million |
| Property, Plant & Equipment | — | — | — | Dkr165.49 Million | Dkr221.45 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Dkr1.63 Billion | Dkr888.86 Million | Dkr387.15 Million | Dkr723.89 Million | Dkr1.14 Billion |
| Total Current Liabilities | Dkr664.97 Million | Dkr403.47 Million | Dkr284.58 Million | Dkr195.49 Million | Dkr334.32 Million |
| Long-term Debt | — | Dkr285.33 Million | Dkr0.00 | Dkr320.74 Million | Dkr647.91 Million |
| Net Debt | Dkr-4.09 Billion | Dkr-88.55 Million | Dkr-330.08 Million | Dkr-625.76 Million | Dkr-341.67 Million |
| Total Stockholder Equity | Dkr14.83 Billion | Dkr8.62 Billion | Dkr1.59 Billion | Dkr815.91 Million | Dkr927.80 Million |
| Retained Earnings | Dkr6.29 Million | Dkr-6.16 Billion | Dkr-4.89 Billion | Dkr-4.17 Billion | Dkr-3.31 Billion |
Zealand Pharma A/S Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Zealand Pharma A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Dkr6.53 Billion | Dkr-930.82 Million | Dkr-425.67 Million | Dkr-942.21 Million | Dkr-1.21 Billion |
| Capital Expenditures | Dkr33.37 Million | Dkr13.15 Million | Dkr23.75 Million | Dkr11.71 Million | Dkr22.13 Million |
| Free Cash Flow | Dkr6.50 Billion | Dkr-943.96 Million | Dkr-449.42 Million | Dkr-953.92 Million | Dkr-1.23 Billion |
| Investing Cash Flow | Dkr-2.25 Billion | Dkr-7.33 Billion | Dkr-1.09 Billion | Dkr281.26 Million | Dkr-18.12 Million |
| Financing Cash Flow | Dkr-378.18 Million | Dkr8.29 Billion | Dkr907.01 Million | Dkr587.40 Million | Dkr1.33 Billion |
| Dividends Paid | — | — | — | — | Dkr647.91 Million |
| Stock-Based Compensation | — | Dkr87.03 Million | Dkr61.43 Million | Dkr52.29 Million | Dkr53.50 Million |
| Depreciation | Dkr27.37 Million | Dkr25.85 Million | Dkr25.09 Million | Dkr117.96 Million | Dkr40.25 Million |
| Change in Cash | Dkr4.10 Billion | Dkr30.99 Million | Dkr-619.92 Million | Dkr-59.87 Million | Dkr168.88 Million |
Zealand Pharma A/S Earnings History — EPS Actual vs. Analyst Estimates
Track Zealand Pharma A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 19, 2026 | — | -8.17 | — |
| Nov 12, 2025 | -5.75 | -10.42 | +44.82% |
| Aug 14, 2025 | 105.61 | 109.53 | -3.58% |
| May 08, 2025 | -4.75 | -0.64 | -642.19% |
| Feb 20, 2025 | -4.12 | -4.29 | +3.96% |
| Nov 07, 2024 | -3.77 | -3.47 | -8.65% |
| Aug 15, 2024 | -4.67 | -3.98 | -17.34% |
| May 16, 2024 | -3.71 | -4.20 | +11.67% |